06 September 2024
The Siberian State Medical University (SSMU) in Tomsk has inaugurated a new Preclinical Research Center, facilitating interdisciplinary research on various animal species. The site is certified in accordance with GLP requirements.
“Before entering the market, medical technologies must prove their effectiveness on animals and then on humans according to safety regulations. And these are not only medicines, but also medical products, new surgical interventions,” explained the rector of the Siberian State Medical University, Evgeny Kulikov. He added that at the time of the opening of the center, “works worth slightly more than 120 million rubles have already been contracted and planned.”
It is important to note that the center is the largest in the region and the only site that meets the GLP standard. Kulikov assures that the conditions and infrastructure for the full-cycle development of drugs have been established here. Additionally, the center will provide training for students and postgraduates to complete coursework, diploma, and dissertation work. Its teachers will also prepare students for surgical Olympiads and organize career guidance events for schoolchildren from all over Russia.
PrintNovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
16 May 2024
Eight radiopharmaceuticals registered in Russia since 2023
10 September 2024
First-in-class combination therapy authorised for endometriosis
10 September 2024
Russian cancer vaccine passes preclinical trials
09 September 2024
Gene therapy trial facilitates major vision improvement
09 September 2024